Mayne Pharma Group Ltd Capital Reinvestment Ratio
Mayne Pharma Group Ltd capital reinvestment ratio. Mayne Pharma Group Ltd (MYX) has a Capital Reinvestment Ratio of 0.17x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$31.98 Million) in capital expenditures (AU$5.40 Million). Check MYX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Mayne Pharma Group Ltd (2010–2025)
Capital reinvestment ratio of Mayne Pharma Group Ltd from 2010 to 2025. This chart tracks Mayne Pharma Group Ltd's Capital Reinvestment Ratio across 12 annual periods. Also explore MYX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Mayne Pharma Group Ltd Capital Reinvestment Ratio by Year (2010–2025)
Mayne Pharma Group Ltd capital reinvestment ratio by year from 2010 to 2025. For the full cash flow conversion analysis, see Mayne Pharma Group Ltd (MYX) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.70x | AU$17.47 Million | AU$12.28 Million | ▲ +32.3% |
| 2021 | 0.53x | AU$47.26 Million | AU$25.10 Million | ▲ +12.5% |
| 2020 | 0.47x | AU$99.78 Million | AU$47.12 Million | ▲ +322.6% |
| 2019 | 0.11x | AU$106.61 Million | AU$11.91 Million | ▼ -74.9% |
| 2018 | 0.45x | AU$121.50 Million | AU$54.18 Million | ▼ -19.4% |
| 2016 | 0.55x | AU$53.50 Million | AU$29.59 Million | ▲ +197.1% |
| 2015 | 0.19x | AU$22.42 Million | AU$4.17 Million | ▲ +15.8% |
| 2014 | 0.16x | AU$26.14 Million | AU$4.20 Million | ▼ -94.8% |
| 2013 | 3.08x | AU$6.84 Million | AU$21.06 Million | ▲ +1517.0% |
| 2012 | 0.19x | AU$13.39 Million | AU$2.55 Million | ▼ -63.1% |
| 2011 | 0.51x | AU$4.09 Million | AU$2.10 Million | ▲ +1225.0% |
| 2010 | 0.04x | AU$10.26 Million | AU$398.56K | — |